ROBERT H. SUVA

Bob Suva provides technical strategy and analysis for a variety of Black Point Group’s projects in the pharmaceutical and life science area.

Prior to joining Black Point Group, Bob held a variety of positions at IDEXX Laboratories, including Division Vice President for Technology Futures.  He participated in development of the technical strategy for the organization, and managed the evaluation and development of new technologies to implement the strategy.  He has also managed the development of immunoassay, instrument, and pharmaceutical products.  Before IDEXX, Bob was a Senior Scientist at SRI International.

Bob received his Ph.D. in Biochemistry at Brandeis University, and a Bachelor of Science in Biochemistry from Oregon State University.